Explore All SARS-CoV-2 Reagents Below

Leinco Technologies develops and manufactures antibodies, recombinant proteins, Cytokines, and MICRO-ELISA kits in response to the worldwide COVD-19 pandemic. Leinco’s extensive line of SARS-CoV-2 antibodies and antigens are produced at one of the highest functional purity levels in the industry. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) also known as 2019-nCoV, is a positive-sense single-stranded RNA enveloped virus, which causes the coronavirus disease 2019 (COVID-19).

Leinco is ready to collaborate with your organization to help accelerate and be a partner in your research whether that is through the development of diagnostic tests, therapeutics, or vaccines. As Leinco continues to develop new research products, please contact our team to explore new development opportunities!

Cytokine Storm

Understanding cytokine storm and recognizing elevated levels of inflammatory cytokines during COVID-19 infection helps better fight the disease.

Learn More

SARS-CoV-2 Antibodies

Antibody offerings include:

  • Anti-SARS-CoV-2 Spike NTD
  • Anti-SARS-CoV-2 Spike RBD
  • Anti-SARS-CoV-2 Nucleocapsid (N)
  • Polyclonal antibodies targeting ACE2, SARS-CoV, and SARS-CoV-2.
View All Products

SARS-CoV-2 Recombinant Proteins

Leinco’s protein product offerings include:

  • Trimeric Spike protein
  • S1-mFc protein and S2 protein
  • S protein RBD & NTD
  • RBD Protein Variants (Alpha, Beta, Delta Plus, Delta, Kappa, Gamma)
  • Nucleocapsid protein and more!
View All Products

Support Tools and Additional Reagents

Research has identified additional antibodies, proteins, and reagents for furthering COVID-19 research and potentially alleviating SARS-CoV-2 infection and progression. This includes, DPPIV, Cathepsins, Anti-STAT1 and more!

Learn More